Sunshine Biopharma Inc. Finite-Lived Intangible Assets, Net
Sunshine Biopharma Inc. (SBFM) had Finite-Lived Intangible Assets, Net of $1.84 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-13
- 2026-06-30: Finite-Lived Intangible Assets, Net $1.84M.
- 2026-03-31: Finite-Lived Intangible Assets, Net $1.92M.
- 2025-12-31: Finite-Lived Intangible Assets, Net $1.89M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $2.01M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $1.84M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.92M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.89M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.01M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.49M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $3.19M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.02M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $2.94M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $2.45M 10-Q/A · filed 2024-08-20 | |
| 2024-03-31 | $2.07M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $1.44M 10-Q · filed 2025-11-13 | |
| 2023-09-30 | $1.22M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.23M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.44M 10-Q · filed 2024-05-20 | $948.24K 10-Q · filed 2023-08-10 |
| 2022-12-31 | $776.86K 10-Q · filed 2024-11-05 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-21 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-21 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 | |
| 2018-12-31 | $0.00 10-K · filed 2020-05-01 | |
| 2017-12-31 | $0.00 10-K · filed 2019-04-12 | |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 | |
| 2015-12-31 | $615.04K 10-K · filed 2017-04-17 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |